A major discovery by Australian researchers of a key driver of prostate cancer could lead to the next generation of targeted ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are ...

For patients with advanced prostate cancer (aPC), completion of a 12-week supervised exercise regimen leads to a sign ...

Real-world data support trial data on the use of lutetium-177 PSMA-617 in patients with PSMA-positive, metastatic castration-resistant prostate cancer.

In a major development, Union Minister Prataprao Jadhav announced that cancer vaccines for women will be available soon.

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces that through its academic partnership with Cedars-Sinai Medical Center, Cedars-Sinai has received $600, ...

Kairos Pharma (NYSE American: KAPA) announced that Cedars-Sinai Medical Center, through its academic partnership with the company, has received $600 ...

Cases of colorectal, breast and prostate cancer have soared in Slovakia, with doctors diagnosing 62 percent more cases than two decades ago. Experts cite an ageing population, sedentary lifestyles, ...

GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Benjamin Maughan discussing a prospective trial of a structured exercise program to lessen fatigue in patients with ...

(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Ivan de Kouchkovsky discussing the impact of baseline PSMA PET in patients with metastatic ...

Sandberg has been in uniform for well over 40 spring-training camps, but he missed last year as he was undergoing cancer ...